Pfizer Inc. today announced positive results from the Phase 3 TALAPRO-2 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide ...

A new study demonstrates the capability of a streamlined workflow to detect low-level presence of Listeria monocytogenes in ...

The Offering was conducted on a firm commitment basis. AC Sunshine Securities LLC acted as the underwriter for the Offering (the “Underwriter”). Ortoli Rosenstadt LLP acted as U.S. counsel to the ...

OSANG Healthcare partners with KAIST, NANO to develop PCR tests for STIs Innovative partnership aims to enhance diagnostic capabilities for global health challenges ...

Korea lifts Mycoplasma pneumonia outbreak alert after eight months Outbreak alert for respiratory infection officially removed as cases decline sharply ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has partnered with, ...

Home with Dignity, a leading mobile in-home euthanasia service for pets, now offers Phoenix pet owners a compassionate ...

Each cell of the human body contains two meters of DNA. The whole secret lies in the intricate three-dimensional arrangement ...

Quantitative polymerase chain reactions (PCRs) were performed to confirm differentially expressed RBPs in RA fibroblast-like synoviocytes (FLSs) and OA-FLSs, as well as in mice with collagen-induced ...

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

The new technology – Cleavage Under Targeted Accessible Chromatin (CUTAC) – focuses on small, fragmented DNA non-coding ...